These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4966173)

  • 1. [Comparative study of antituberculous action in vitro and in vivo between 1321 Th and 1314 Th].
    Kanai K; Koseki U; Okamoto S; Murohashi T
    Saishin Igaku; 1967 Sep; 22(9):2053-7. PubMed ID: 4966173
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antituberculous action and clinical effects of alpha-propyl-thioisonicotinamide (1321 TH)].
    Yamamoto K; Sakurai H; Inoue I; Sasaoka M; Hashimoto T
    Saishin Igaku; 1967 Sep; 22(9):2087-97. PubMed ID: 4966177
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental and clinical evaluation of alpha-propyl-2-thioisonicotinamide (1321 TH)].
    Kawamori U; Soejima R; Tagawa K; Nagao T; Nozute H
    Saishin Igaku; 1967 Sep; 22(9):2066-72. PubMed ID: 4966175
    [No Abstract]   [Full Text] [Related]  

  • 4. [Concentration of ethionamide and prothionamide in the blood of patients with pulmonary tuberculosis].
    Bialik IB; Kalabukha AV
    Vrach Delo; 1973 Nov; 11():97-100. PubMed ID: 4206857
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison between antituberculous activity of alpha-ethyl-thioisonicotinamide (1314 TH) and alpha-N-propylthioisonicotinamide (1321 TH) in vitro].
    Tamura M; Takano S
    Kekkaku; 1971 May; 46(5):137-52. PubMed ID: 4996120
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mode of action of "tuverculostatics". Consequences for the therapy].
    Krebs A
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):208-17. PubMed ID: 4973006
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antitubercular effect of ethionamide in vitro and in experimental tuberculosis].
    Bialik IB
    Mikrobiol Zh; 1966; 28(5):65-70. PubMed ID: 4966793
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the antibacterial power of 1321 Th in vitro and its antibacterial action in combination with antitubercular agents (secondary)].
    Yamazaki M
    Saishin Igaku; 1967 Sep; 22(9):2083-6. PubMed ID: 4966176
    [No Abstract]   [Full Text] [Related]  

  • 9. [Some questions on chemotherapy with ethionamide].
    Utkin VV; Fedorova IE
    Probl Tuberk; 1967; 45(7):49-55. PubMed ID: 4974096
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative characteristics of the effectiveness and tolerance of ethionamide and prothionamide in the clinical treatment of pulmonary tuberculosis].
    Bialik IB; Kalabukha AV
    Probl Tuberk; 1973; 51(10):37-40. PubMed ID: 4784035
    [No Abstract]   [Full Text] [Related]  

  • 11. Tuberculous meningitis due to primary drug-resistant Mycobacterium tuberculosis hominis.
    Bonforte RJ; Karpas CM; Gribetz I; Shanzer S
    Pediatrics; 1968 Dec; 42(6):969-75. PubMed ID: 4973145
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 13. [Basic study of 1321 TH].
    Gomi J; Aoyagi T
    Saishin Igaku; 1967 Sep; 22(9):2081-2. PubMed ID: 6082218
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative study of the susceptibility to ethionamide and isoniazid of tubercle bacilli from patients never treated with ethionamide.
    Hok TT; Seng TK
    Paediatr Indones; 1967; 7(1):32-8. PubMed ID: 4963150
    [No Abstract]   [Full Text] [Related]  

  • 15. [Basic study on the antibacterial power of 1321 TH].
    Ogawa M
    Saishin Igaku; 1967 Sep; 22(9):2058-65. PubMed ID: 4966174
    [No Abstract]   [Full Text] [Related]  

  • 16. [A comparative study on clinical efficacy of rifampicin (RFP), ethambutol (EB) and ethionamide (1321 TH) in retreatment of pulmonary tuberculosis. Report of the 13th series study part B].
    Kekkaku; 1972 May; 47(5):139-44. PubMed ID: 5042532
    [No Abstract]   [Full Text] [Related]  

  • 17. [The resistance of Mycobacterium tuberculosis to ethionamide, thiosemicarbazone and isoxyl and their relations to each other].
    Eule H; Werner E
    Beitr Klin Erforsch Tuberk Lungenkr; 1967; 134(4):247-58. PubMed ID: 4968300
    [No Abstract]   [Full Text] [Related]  

  • 18. [Basic and clinical study of 2-propyl isonicotinic thioamide (1321 Th)].
    Hokama S; Naruto H; Sugiura H; Matsumiya T; Fukuhara Y
    Saishin Igaku; 1967 Sep; 22(9):2073-80. PubMed ID: 6082217
    [No Abstract]   [Full Text] [Related]  

  • 19. [Restoration of drug sensitivity in Mycobacterium tuberculosis to streptomycin and isoniazid during treatment with preparations of the 1st series].
    Rudoĭ NM; Utkin VV; Fedorova IE; Afanas'eva IuP
    Antibiotiki; 1970 Apr; 15(4):355-7. PubMed ID: 4993044
    [No Abstract]   [Full Text] [Related]  

  • 20. [Criteria of clinical resistance of cycloserine, ethionamide and ethambutol].
    Okamoto K; Watanabe S; Terunuma K
    Kekkaku; 1970 Feb; 45(2):65-72. PubMed ID: 4985702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.